USANA Resurfacing Serum Clinical Study

A clinical study was conducted by USANA Health Sciences to evaluate the efficacy and tolerance of Celavive Resurfacing Serum. Celavive Resurfacing Serum is a topical skincare product that contains a blend of alpha and beta hydroxy acids, niacinamide, peptides, and bakuchiol.

Study Design

The study included 33 women with mild to moderate skin concerns. They used USANA Resurfacing serum for 12 weeks. The women came from different races and ethnicities, and they were between 39 and 65 years old, with an average age of 56.

Clinical skin measurements were taken before the participants began using Resurfacing Serum, and again after using the product for 2, 4, 8, and 12 weeks. The participants also completed a self-assessment questionnaire to evaluate how they felt about their skin after using the product.

Results

Resurfacing Serum was well-tolerated by all the subjects. Users showed statistically significant improvements in the appearance of their skin in just two weeks. These measurements further improved as they continued to use the product through weeks 4, 8, and 12.

Over 80% reported that it was the best their skin had felt in a long time. Some of the specific improvements they saw were that Resurfacing Serum helped their skin appear clearer, firmer, and more radiant. It helped reduce the appearance of pores, fine lines, and wrinkles. They also reported that the product was easy to use, and 97% of them said that they would recommend the product to others.

For detailed information, please visit askthescientists.com